BPC-157 & TB-500 Blend 20mg is supplied strictly for in-vitro laboratory research and analytical investigation
The 'LR3' designation refers to a 13-amino-acid N-terminal extension and a glutamic acid substitution at position 3, which together reduce binding affinity for IGF-binding proteins (IGFBPs) by approximately 100-fold
Nonetheless, the discovery of this sequence has enabled the laboratory synthesis of this short peptide using a relatively-straightforward chemical process
While these mechanisms are biologically plausible, theres currently no evidence that they translate into reduced cardiovascular events or meaningful clinical outcomes.31 Exercise performance and recovery Since astaxanthin concentrates in mitochondria and muscle tissue, its also been studied for its role in physical endurance
Solymoss BC, Bourassa MG, Lesprance J, Levesque S, Marcil M, Varga S, Campeau L
BPC/TB Capsules combine 500mcg of BPC-157 and 500mcg of TB-500 per capsule, delivering a total of 1000mcg in each dose